The non-invasive solution for comprehensive management of liver health
Powered by LSM by VCTE™, CAP™ and SSM by VCTE™ for liver disease management.
A painless exam performed in less than 10 minutes to provide immediate results at the point-of-care.
Can be performed by any trained operator (physician, nurse).
The non-invasive solution validated by 3,500+ peer-reviewed publications and 160+ international guidelines.
Standardized examination with exceptional precision and reproducibility that can be utilized in 99% of patients
Equipped with patented technology and proprietary algorithms to deliver consistently accurate results.
Optimize clinical workflows with real-time secure data transmission
Fit the patient morphology with the appropriated probe
Enhance FibroScan® liver disease assessment with biological markers
* additional cost
The FibroScan® Family of Products (models: 502 Touch, 530 Compact, 430 Mini+, and 630) is intended to provide shear wave speed measurements and estimates of tissue stiffness as well as ultrasound coefficient of attenuation (CAP: Controlled Attenuation Parameter) in internal structures of the body. The Shear wave speed and stiffness measurements may be used as an aid to clinical management of adult patients with liver disease. The FibroScan® Family of Products (models: 502 Touch, 530 Compact, 430 Mini+, and 630) is indicated for non-invasive measurement in the liver of 50 Hz shear wave speed and estimates of stiffness as well as determining a 3.5 MHz ultrasound coefficient for the Attenuation Parameter (CAP: Controlled Attenuation Parameter).
The shear wave speed and stiffness, and CAP* may be used as an aid to diagnosis and monitoring of adult patients with liver disease, as part of an overall assessment of the liver.
Shear wave speed and stiffness may be used as an aid in the clinical management of pediatric patients with liver disease. FibroScan® 630 (Expert) is also indicated for noninvasive measurement in the spleen of 100 Hz shear wave speed and estimates of stiffness that may be used as an aid to diagnosis, monitoring and clinical management of adult patients with liver disease, as part of an overall assessment of the liver. * CAP for pediatric patients with liver disease is only available with SmartExam capability.
The FibroScan® 230 is intended to provide shear wave speed measurements and estimates of tissue stiffness as well as ultrasound coefficient of attenuation (CAP: Controlled Attenuation Parameter) in internal structures of the body. The Shear wave speed and stiffness measurements may be used as an aid to clinical management of adult patients with liver disease. FibroScan® 230 is indicated for non-invasive measurement in the liver of 50 Hz shear wave speed and estimates of stiffness as well as determining a 3.5 MHz ultrasound coefficient of attenuation (CAP: Controlled Attenuation Parameter). Shear wave speed, stiffness and CAP may be used as an aid to diagnosis and monitoring of adult patients with liver disease, as part of an overall assessment of the liver. Shear wave speed, stiffness and CAP may be used as an aid in the clinical management of pediatric patients with liver disease.
FibroScan®
